Selected research
Industry Research
Coronavirus Spike Protein Industry Research Report 2026
Market perspective
The global Coronavirus Spike Protein market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Coronavirus Spike Protein is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Coronavirus Spike Protein is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Coronavirus Spike Protein is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Coronavirus Spike Protein include Seebio, Sanofi, Thermo Fisher Scientific, The Native Antigen Company, Sinobiological, Novus Biologicals, Merck KGaA (Sigma-Aldrich), Elabscience and Eagle Biosciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Coronavirus Spike Protein market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Coronavirus Spike Protein Market by Company
Seebio
Sanofi
Thermo Fisher Scientific
The Native Antigen Company
Sinobiological
Novus Biologicals
Merck KGaA (Sigma-Aldrich)
Elabscience
Eagle Biosciences
BiosPacific
Bio-Rad Laboratories
Agrisera
Abcam
Coronavirus Spike Protein Segment by Type
90%≤Purity≤95%
Purity＞95%
Other
Coronavirus Spike Protein Segment by Application
RDT & ELISA
Antiviral Drugs
Research
Vaccine Development
Other
Coronavirus Spike Protein Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coronavirus Spike Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Coronavirus Spike Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coronavirus Spike Protein.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Coronavirus Spike Protein manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Coronavirus Spike Protein by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Coronavirus Spike Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 90%≤Purity≤95%
- Purity＞95%
- Other
Applications
- RDT & ELISA
- Antiviral Drugs
- Research
- Vaccine Development
- Other
Companies covered
- Seebio
- Sanofi
- Thermo Fisher Scientific
- The Native Antigen Company
- Sinobiological
- Novus Biologicals
- Merck KGaA (Sigma-Aldrich)
- Elabscience
- Eagle Biosciences
- BiosPacific
- Bio-Rad Laboratories
- Agrisera
- Abcam
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Coronavirus Spike Protein Market Size (2021-2032)
- 2.2.2 Global Coronavirus Spike Protein Sales (2021-2032)
- 2.2.3 Global Coronavirus Spike Protein Market Average Price (2021-2032)
- 2.3 Coronavirus Spike Protein by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 90%≤Purity≤95%
- 2.3.3 Purity＞95%
- 2.3.4 Other
- 2.4 Coronavirus Spike Protein by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 RDT & ELISA
- 2.4.3 Antiviral Drugs
- 2.4.4 Research
- 2.4.5 Vaccine Development
- 2.4.6 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Coronavirus Spike Protein Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Coronavirus Spike Protein Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Coronavirus Spike Protein Revenue of Manufacturers (2021-2026)
- 3.4 Global Coronavirus Spike Protein Average Price by Manufacturers (2021-2026)
- 3.5 Global Coronavirus Spike Protein Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Coronavirus Spike Protein, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Coronavirus Spike Protein, Product Type & Application
- 3.8 Global Manufacturers of Coronavirus Spike Protein, Established Date
- 3.9 Global Coronavirus Spike Protein Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Seebio
- 4.1.1 Seebio Company Information
- 4.1.2 Seebio Business Overview
- 4.1.3 Seebio Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Seebio Coronavirus Spike Protein Product Portfolio
- 4.1.5 Seebio Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Coronavirus Spike Protein Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Thermo Fisher Scientific
- 4.3.1 Thermo Fisher Scientific Company Information
- 4.3.2 Thermo Fisher Scientific Business Overview
- 4.3.3 Thermo Fisher Scientific Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Thermo Fisher Scientific Coronavirus Spike Protein Product Portfolio
- 4.3.5 Thermo Fisher Scientific Recent Developments
- 4.4 The Native Antigen Company
- 4.4.1 The Native Antigen Company Company Information
- 4.4.2 The Native Antigen Company Business Overview
- 4.4.3 The Native Antigen Company Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 The Native Antigen Company Coronavirus Spike Protein Product Portfolio
- 4.4.5 The Native Antigen Company Recent Developments
- 4.5 Sinobiological
- 4.5.1 Sinobiological Company Information
- 4.5.2 Sinobiological Business Overview
- 4.5.3 Sinobiological Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sinobiological Coronavirus Spike Protein Product Portfolio
- 4.5.5 Sinobiological Recent Developments
- 4.6 Novus Biologicals
- 4.6.1 Novus Biologicals Company Information
- 4.6.2 Novus Biologicals Business Overview
- 4.6.3 Novus Biologicals Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Novus Biologicals Coronavirus Spike Protein Product Portfolio
- 4.6.5 Novus Biologicals Recent Developments
- 4.7 Merck KGaA (Sigma-Aldrich)
- 4.7.1 Merck KGaA (Sigma-Aldrich) Company Information
- 4.7.2 Merck KGaA (Sigma-Aldrich) Business Overview
- 4.7.3 Merck KGaA (Sigma-Aldrich) Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Merck KGaA (Sigma-Aldrich) Coronavirus Spike Protein Product Portfolio
- 4.7.5 Merck KGaA (Sigma-Aldrich) Recent Developments
- 4.8 Elabscience
- 4.8.1 Elabscience Company Information
- 4.8.2 Elabscience Business Overview
- 4.8.3 Elabscience Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Elabscience Coronavirus Spike Protein Product Portfolio
- 4.8.5 Elabscience Recent Developments
- 4.9 Eagle Biosciences
- 4.9.1 Eagle Biosciences Company Information
- 4.9.2 Eagle Biosciences Business Overview
- 4.9.3 Eagle Biosciences Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Eagle Biosciences Coronavirus Spike Protein Product Portfolio
- 4.9.5 Eagle Biosciences Recent Developments
- 4.10 BiosPacific
- 4.10.1 BiosPacific Company Information
- 4.10.2 BiosPacific Business Overview
- 4.10.3 BiosPacific Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 BiosPacific Coronavirus Spike Protein Product Portfolio
- 4.10.5 BiosPacific Recent Developments
- 4.11 Bio-Rad Laboratories
- 4.11.1 Bio-Rad Laboratories Company Information
- 4.11.2 Bio-Rad Laboratories Business Overview
- 4.11.3 Bio-Rad Laboratories Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Bio-Rad Laboratories Coronavirus Spike Protein Product Portfolio
- 4.11.5 Bio-Rad Laboratories Recent Developments
- 4.12 Agrisera
- 4.12.1 Agrisera Company Information
- 4.12.2 Agrisera Business Overview
- 4.12.3 Agrisera Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Agrisera Coronavirus Spike Protein Product Portfolio
- 4.12.5 Agrisera Recent Developments
- 4.13 Abcam
- 4.13.1 Abcam Company Information
- 4.13.2 Abcam Business Overview
- 4.13.3 Abcam Coronavirus Spike Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Abcam Coronavirus Spike Protein Product Portfolio
- 4.13.5 Abcam Recent Developments
5 Global Coronavirus Spike Protein Market Scenario by Region
- 5.1 Global Coronavirus Spike Protein Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Coronavirus Spike Protein Sales by Region: 2021-2032
- 5.2.1 Global Coronavirus Spike Protein Sales by Region: 2021-2026
- 5.2.2 Global Coronavirus Spike Protein Sales by Region: 2027-2032
- 5.3 Global Coronavirus Spike Protein Revenue by Region: 2021-2032
- 5.3.1 Global Coronavirus Spike Protein Revenue by Region: 2021-2026
- 5.3.2 Global Coronavirus Spike Protein Revenue by Region: 2027-2032
- 5.4 North America Coronavirus Spike Protein Market Facts & Figures by Country
- 5.4.1 North America Coronavirus Spike Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Coronavirus Spike Protein Sales by Country (2021-2032)
- 5.4.3 North America Coronavirus Spike Protein Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Coronavirus Spike Protein Market Facts & Figures by Country
- 5.5.1 Europe Coronavirus Spike Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Coronavirus Spike Protein Sales by Country (2021-2032)
- 5.5.3 Europe Coronavirus Spike Protein Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Coronavirus Spike Protein Market Facts & Figures by Country
- 5.6.1 Asia Pacific Coronavirus Spike Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Coronavirus Spike Protein Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Coronavirus Spike Protein Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Coronavirus Spike Protein Market Facts & Figures by Country
- 5.7.1 South America Coronavirus Spike Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Coronavirus Spike Protein Sales by Country (2021-2032)
- 5.7.3 South America Coronavirus Spike Protein Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Coronavirus Spike Protein Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Coronavirus Spike Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Coronavirus Spike Protein Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Coronavirus Spike Protein Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Coronavirus Spike Protein Sales by Type (2021-2032)
- 6.1.1 Global Coronavirus Spike Protein Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Coronavirus Spike Protein Sales Market Share by Type (2021-2032)
- 6.2 Global Coronavirus Spike Protein Revenue by Type (2021-2032)
- 6.2.1 Global Coronavirus Spike Protein Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Coronavirus Spike Protein Revenue Market Share by Type (2021-2032)
- 6.3 Global Coronavirus Spike Protein Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Coronavirus Spike Protein Sales by Application (2021-2032)
- 7.1.1 Global Coronavirus Spike Protein Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Coronavirus Spike Protein Sales Market Share by Application (2021-2032)
- 7.2 Global Coronavirus Spike Protein Revenue by Application (2021-2032)
- 7.2.1 Global Coronavirus Spike Protein Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Coronavirus Spike Protein Revenue Market Share by Application (2021-2032)
- 7.3 Global Coronavirus Spike Protein Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Coronavirus Spike Protein Value Chain Analysis
- 8.1.1 Coronavirus Spike Protein Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Coronavirus Spike Protein Production Mode & Process
- 8.2 Coronavirus Spike Protein Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Coronavirus Spike Protein Distributors
- 8.2.3 Coronavirus Spike Protein Customers
9 Global Coronavirus Spike Protein Analyzing Market Dynamics
- 9.1 Coronavirus Spike Protein Industry Trends
- 9.2 Coronavirus Spike Protein Industry Drivers
- 9.3 Coronavirus Spike Protein Industry Opportunities and Challenges
- 9.4 Coronavirus Spike Protein Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst